Table 2 Muscle strength (predicted) and STS for each group.

Diagnostic group	Quadriceps strength (%)†	Hamstrings strength (%)†	STS (s)†
Extra‐pyramidal	81.3 (36.4),	65.7 (30.6),*	2.5 (0.9),*
(n = 15)	−48.8 to 11.6	13.9 to 57.0	0.1 to 1.1‡
Pyramidal	67.2 (30.7),**	55.9 (33.5),**	2.9 (1.2),**
(n = 12)	12.1 to 65.4	19.4 to 67.1	0.2 to 1.7‡
LMN (sensory	53.4 (38.0),**	55.6 (20.5),*	2.9 (0.9),*
intact) (n = 12)	21.5 to 78.3	30.2 to 70.5	−2.1 to 0.6‡
LMN (sensory	87.4 (27.5),	61.4 (22.4),**	2.8 (1.7),*
loss) (n = 18)	−45.3 to 0.6	31.4 to 66.2	−0.1 to 1.2‡
Muscle disease	50.6 (30.1),**	55.9 (42.7),**	3.3 (1.6),**
(n = 17)	36.9 to 88.7	32.7 to 85.4	0.4 to 2.2‡
Grouped	68.9 (34.9)	59.2 (30.7)	2.9 (1.3)
neurology
subjects (n = 74)
Control	102.4 (37.0)	103.2 (30.1)	2.0 (0.59)
subjects (n = 32)

LMN, lower motor neuron.

†Values are mean (SD), 95% CI difference; ‡non‐parametric comparisons between groups were used (approximate confidence intervals presented).

*p⩽0.05;**p⩽0.01 when compared to a separately matched control group.